www.khabarexpress.com : The news portal of North India
www.khabarexpress.com
Looking Suitable Software for your Business
Pelagian Softwares Restaurant Photo Colour Lab Wool - Stock Yellow Pages
Jewellery PS Accounting e-Dictionary Payroll
Download Trial Now
Welcome Guest Sign In  New user! Sign Up Now | My Favourites (new)
Search Photo  
RSS Feed
09 January 2009
Forum | Wallpapers | Photo Gallery | Business | Entertainment | Education | Sports | Article | City | Election |
Free News on your website


Type 2 diabetes ups carcinoma risk
30 Oct 2008, 1554 Hrs

Add comment          Mail          Print          Write to Editor



 Educational Short Stories in Hindi

Washington, October 30 An Italian study has revealed that patients with type 2 diabetes mellitus (DM2) have a significantly increased risk of hepatocellular carcinoma (HCC).

Dr. Valter Donadon from Pordenone Hospital of Italy, who investigated the relationships between DM2 and risk of HCC in a large population based case-control study, also found that DM2 pre-exists to the development of HCC in most cases.

Describing the study in the World Journal of Gastroenterology, Donadon said that the research team had enrolled 465 consecutive patients with HCC compared with an age and sex matched control group of 490 subjects.

The researcher said that the new findings suggested that DM2 is more likely a concourse rather than merely a consequence of the liver tumour, a conclusion supported by the finding of a similar frequency and severity of DM2 in patients with small HCC detected during follow-up of cirrhosis and in those with more advanced and diffuse cancers detected outside of a surveillance program.

The researchers said that the observation that patients with DM2, particularly males, treated with insulin had an increased frequency of HCC was intriguing and clinically relevant.

According to them, their findings go to show that it is very important to closely observe HCC in patients with chronic liver disease and DM2, particularly when males are treated with insulin.

They further said that the in such patients strategies to improve the metabolic control should be directed primarily against hyperinsulinaemia by avoiding as much as possible the use of oral secretogogue drugs and of insulin treatment, giving preference to insulin-sensitizers such as metformin and glitazones.

Given that diabetes may be secondary to HCC or to the underlying cirrhosis, and the liver cirrhosis may be caused by diabetes, the researchers believe that further studies involving cirrhotic patients can help evaluate these complex relationships, and particularly whether the diabetes itself has a direct carcinogenetic effect. (ANI)




Discuss this story on KhabarExpress Forum  


Comments to this News

Be the first to comment on this News


 
Post Your Comments to this News
 Posting Rules
Name: Email:

Top Story of The Day
Latest Articles

Deepika and Saharukh Khan in upcoming movie Billu Barbar

Neha Dhupia


Education Special

All right reserved by Khabarexpress.com
Contact Us | Archives | Sitemap | Can't see Hindi ?
Special Edition: Lakshchandi Mahayagya, Camel Festival 2007, Vartmaan Sahitya, Bikaner Udyog Craft Mela
Our Network rajb2b.com | khabarexpress.com | uniqueidea.net | hindinotes.com